Enterovirus diversity may limit treatment advances
Background
Enteroviruses are significant pathogens in pediatric populations, causing a range of diseases from mild illnesses to severe conditions like meningitis and myocarditis. The complexity of enterovirus infections, coupled with their genetic diversity, poses substantial challenges for effective treatment and prevention strategies.
Data Highlights
No numerical data available.
Key Findings
- Enteroviruses account for approximately 58% of meningitis or encephalitis cases in children.
- Reverse transcription–polymerase chain reaction (RT-PCR) has a sensitivity of over 95% for EV diagnosis.
- Current treatment for EV infections is primarily supportive, as no antiviral drug is approved for routine clinical use.
- Investigational antiviral agents have shown limited efficacy and many remain in preclinical stages.
- The inactivated EV-A71 vaccine has shown efficacy against severe HFMD but does not provide cross-protection against other enteroviruses.
Clinical Implications
Clinicians should be aware of the limitations in current treatment options for enterovirus infections and the importance of supportive care.
Conclusion
The genetic diversity of enteroviruses complicates the development of effective treatments and vaccines.
Related Resources & Content
- Xiangpeng Chen, et al., Enterovirus diversity may limit treatment advances
- MDSpire News — Triple Drug Combo May Halt Enterovirus Infections
- The Journal of Infectious Diseases — Clinical and Epidemiological Analysis of Enterovirus Activity in Europe from 2018 to 2023: A Retrospective Multicenter Surveillance Study
- The Journal of Infectious Diseases — Cluster of Aseptic Meningitis Cases Linked to a Newly Discovered Recombinant Echovirus 6/Coxsackievirus B1 Enterovirus
- International Journal of Infectious Diseases — Trends in Neutralizing Antibody Levels Against Enterovirus D68 in Adults Amid the COVID-19 Pandemic
- Triple Drug Combo May Halt Enterovirus Infections
- Clinical and Epidemiological Analysis of Enterovirus Activity in Europe from 2018 to 2023
- Cluster of Aseptic Meningitis Cases Linked to a Newly Discovered Recombinant Echovirus 6/Coxsackievirus B1 Enterovirus
- Acute Flaccid Myelitis (AFM) | CDC
- Clinical Overview of Enterovirus D68 | CDC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
